tiprankstipranks
Oxford BioMedica plc (OXBDF)
OTHER OTC:OXBDF
US Market
OXBDF
Oxford BioMedica
RESEARCH TOOLSreports
Want to see OXBDF full AI Analyst Report?

Oxford BioMedica (OXBDF) Income Statement

64 Followers

Oxford BioMedica Income Statement

Last quarter (Q4 2025), Oxford BioMedica's total revenue was £95.52M, an increase of 105.51% from the same quarter last year. In Q4, Oxford BioMedica's net income was £-3.77M. See Oxford BioMedica’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
£ 168.74M£ 128.80M£ 89.54M£ 139.99M£ 142.80M
Gross Profit
£ 65.98M£ 53.02M£ 39.73M£ 69.18M£ 82.64M
Operating Expenses
£ 99.52M£ 92.40M£ 223.90M£ 120.74M£ 61.71M
Depreciation and Amortization
£ 0.00£ 23.09M£ 28.71M£ 26.43M£ 12.46M
EBITDA
£ -33.54M£ -14.33M£ -148.62M£ -10.80M£ 33.22M
Operating Income
£ -33.54M£ -39.38M£ -184.17M£ -30.22M£ 20.77M
Other Income/Expenses
£ 1.61M£ -7.89M£ -4.35M£ -15.76M£ -888.00K
Pretax Income
£ -31.94M£ -47.27M£ -188.53M£ -45.98M£ 19.88M
Net Income
£ -30.13M£ -43.19M£ -157.49M£ -39.16M£ 19.01M
Per Share Metrics
Basic EPS
£ -0.27£ -0.42£ -1.63£ -0.41£ 0.23
Diluted EPS
£ -0.27£ -0.42£ -1.63£ -0.41£ 0.22
Weighted Average Shares Outstanding
 111.92M 103.46M 96.56M 94.83M 83.48M
Weighted Average Shares Outstanding (Diluted)
 111.92M 103.46M 96.56M 94.83M 85.62M
Currency in GBP

Oxford BioMedica Earnings and Revenue History